MedPath

To study the effects of the Systane COMPLETE eye drops in the treatment of dry eye disease in diabetic patients

Not Applicable
Conditions
Health Condition 1: H00-H59- Diseases of the eye and adnexa
Registration Number
CTRI/2023/05/052501
Lead Sponsor
Alcon Laboratories Ind Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Diabetic subjects between 18-55 yrs, who present to hospital with symptoms of dry eye and having Ocular Surface Disease Index (OSDI) score between 13-32

Exclusion Criteria

1.Subjects already diagnosed with dry eyes secondary to any other cause.

2.Subjects diagnosed to have severe dry eye

3.Subjects who have undergone previous ocular surgery.

4.Subjects who are on treatment with other Artificial tear products or previously diagnosed with other ocular pathologies.

5.Subjects who have used contact lenses within the last 6 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in symptom scoreTimepoint: 1 MONTH
Secondary Outcome Measures
NameTimeMethod
Improvement in tear film parameters (Schirmerâ??s, NIBUT, Corneal staining scores and keratograph)Timepoint: 1 MONTH
© Copyright 2025. All Rights Reserved by MedPath